Texas Cardiac Arrhythmia Institute   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Austin TX United States (1996)

Organization Overview

First Clinical Trial
2008
NCT00729911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

St. David`s Medical Center | Texas Cardiac Arrhythmia Institute, St. David's Medical Center | Texas Cardiac Arrhythmia Research Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Heart Failure (Phase 4)

Ischemia (Phase 4)

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Thromboembolism (Phase 3)

Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12